Functional Lecithin:Cholesterol Acyltransferase Deficiency and High Density Lipoprotein Deficiency in Transgenic Mice Overexpressing Human Apolipoprotein A-II

This publication has 38 references indexed in Scilit:

• Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
  Journal of Clinical Investigation, 1994
• Interaction of apolipoprotein AII with the putative high-density lipoprotein receptor
  Biochemistry, 1993
• Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.
  Proceedings of the National Academy of Sciences, 1991
• Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
  Proceedings of the National Academy of Sciences, 1991
• Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H
  Atherosclerosis, 1987
• Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit
  Nature, 1985
• Activation of the Enzymic Activity of Hepatic Lipase by Apolipoprotein A‐II
  European Journal of Biochemistry, 1983
• High density lipoprotein as a protective factor against coronary heart disease
  The American Journal of Medicine, 1977
• PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
  The Lancet, 1975
• Amino Acid Sequence of Human apoLp-Gln-II (apoA-II), an Apolipoprotein Isolated from the High-Density Lipoprotein Complex
  Proceedings of the National Academy of Sciences, 1972